{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:41:02Z","timestamp":1791902462800,"version":"4.3.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.clim.2018.11.009","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T03:47:50Z","timestamp":1548560870000},"page":"39-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Precursor B-cell development in bone marrow of Good syndrome patients"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-097X","authenticated-orcid":false,"given":"Luc\u00eda","family":"del Pino Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Wentink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"van Deuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Martin","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.I. Edvard","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1510-3104","authenticated-orcid":false,"given":"Mirjam","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clim.2018.11.009_bb0005","first-page":"1010","article-title":"Thymic tumor and acquired agammaglobulinemia: a clinical and experimental study of the immune response","volume":"40","author":"Good","year":"1956","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.clim.2018.11.009_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clim.2010.01.006","article-title":"Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence","volume":"135","author":"Kelesidis","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.009_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clim.2016.07.025","article-title":"Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective","volume":"171","author":"Jansen","year":"2016","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2018.11.009_bb0020","first-page":"437","article-title":"Pre-B cell suppression by thymoma patient lymphocytes","volume":"48","author":"Hayward","year":"1982","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2018.11.009_bb0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2169\/internalmedicine.33.496","article-title":"Goods-syndrome with a block in the early-stage of B-cell differentiation and complicated by campylobacter-fetus sepsis","volume":"33","author":"Yamazaki","year":"1994","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.clim.2018.11.009_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00018-011-0836-x","article-title":"New frontiers of primary antibody deficiencies","volume":"69","author":"van der Burg","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.clim.2018.11.009_bb0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1081-1206(10)60695-3","article-title":"Thymoma and immunodeficiency (Good syndrome): a report of 2 unusual cases and review of the literature","volume":"98","author":"Agarwal","year":"2007","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.clim.2018.11.009_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clim.2014.04.002","article-title":"BAFF-R mutations in good's syndrome","volume":"153","author":"Lougaris","year":"2014","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2018.11.009_bb0045","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2298\/VSP140609102T","article-title":"Good's syndrome with increasing gammadelta T-lymphocyte subpopulation: a case report","volume":"72","author":"Tadic","year":"2015","journal-title":"Vojnosanit. Pregl."},{"issue":"34","key":"10.1016\/j.clim.2018.11.009_bb0050","doi-asserted-by":"crossref","first-page":"36577","DOI":"10.18632\/oncotarget.5369","article-title":"Good syndrome presenting with CD8(+) T-Cell large granular lymphocyte leukemia","volume":"6","author":"Caperton","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.clim.2018.11.009_bb0055","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1182\/blood-2002-08-2638","article-title":"Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia","volume":"101","author":"Maria Masci","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clim.2018.11.009_bb0060","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4049\/jimmunol.1301815","article-title":"A feeder-free differentiation system identifies autonomously proliferating B cell precursors in human bone marrow","volume":"192","author":"Kraus","year":"2014","journal-title":"J. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618305011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618305011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:58:50Z","timestamp":1761494330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618305011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":12,"alternative-id":["S1521661618305011"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.11.009","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precursor B-cell development in bone marrow of Good syndrome patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}